Please assess the completion status of the following clinical trial:

Trial Title: Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Diagnosis of patellofemoral pain syndrome (PFPS) or non-specific anterior knee pain (NSAKP) and plan to attend Gaylord Specialty Healthcare Physical Therapy~Exclusion Criteria:~Member of a defined vulnerable population, women who are or suspected to be pregnant, prisoners, children under 15, or other protected populations~Body mass of the leg preventing the cuff from fitting properly~Radiographic evidence of osteoarthritis (≥ Kellgren-Lawrence Grade 2)~History of intra-articular injection into either knee within 3 -months~Uncontrolled or untreated inflammatory disorder~Acute inflammatory disorder~Uncontrolled Diabetes and/or peripheral neuropathy, impaired circulation~Uncontrolled cardiac conditions including uncontrolled hypertension~Areas of thrombophlebitis, thrombosis~Distal wounds or pain below the knee \>4/10~History of or current rhabdomyolysis~Prolonged immobilization (\>3 months)~Sickle cell anemia~Lymphadenectomy~Varicose veins, or a history of personal or immediate family history (parental or sibling) of deep vein thrombosis~Current infection at or below the level of cuff placement~Malignancies in or below the area to be treated~Other conditions/medications that would interfere with subject safety or data collection in the opinion of the PI~Subjects with an increased risk of non-response as determined by the therapist~Once entered in the study, a diagnosis change that affects participation

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Blood flow restriction and standard of care therapy (Type: EXPERIMENTAL): The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength.
- Sham and standard of care therapy (Type: PLACEBO_COMPARATOR): The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases.

Based on this trial design, predict the completion outcome and termination type (if applicable).